1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. PHARMACEUTICAL MANUFACTURING ROBOTICS MARKET BY ROBOT TYPE
5.1. Introduction
5.2. Articulated Robots
5.3. SCARA Robots
5.4. Delta Robots
5.5. Collaborative Robots
5.6. Cartesian Robots
6. PHARMACEUTICAL MANUFACTURING ROBOTICS MARKET BY APPLICATION
6.1. Introduction
6.2. Drug Discovery
6.3. Clinical Trials
6.4. Pharmaceutical Packaging
6.5. Laboratory Automation
6.6. Material Handling
6.7. Assembly
7. PHARMACEUTICAL MANUFACTURING ROBOTICS MARKET BY END-USER
7.1. Introduction
7.2. Pharmaceutical Companies
7.3. Research Laboratories
7.4. Contract Manufacturing Organisations (CMOs)
8. PHARMACEUTICAL MANUFACTURING ROBOTICS MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. United States
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. United Kingdom
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Others
8.5. Middle East & Africa
8.5.1. Saudi Arabia
8.5.2. UAE
8.5.3. Others
8.6. Asia Pacific
8.6.1. Japan
8.6.2. China
8.6.3. India
8.6.4. South Korea
8.6.5. Taiwan
8.6.6. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. ABB Ltd.
10.2. Fanuc Corporation
10.3. KUKA AG
10.4. Yaskawa Electric Corporation
10.5. Mitsubishi Electric Corporation
10.6. Staubli Robotics
10.7. Denso Corporation
10.8. Universal Robots (part of Teradyne)
10.9. Kawasaki Heavy Industries, Ltd.
10.10. Epson Robots (Seiko Epson Corporation)
11. APPENDIX
11.1. Currency
11.2. Assumptions
11.3. Base and Forecast Years Timeline
11.4. Key benefits for the stakeholders
11.5. Research Methodology
11.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES